{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T00:37:50Z","timestamp":1795221470728,"version":"4.10.3"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018568","name":"Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province","doi-asserted-by":"publisher","award":["STKJ2023003"],"award-info":[{"award-number":["STKJ2023003"]}],"id":[{"id":"10.13039\/501100018568","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jhepr.2025.101602","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:28:27Z","timestamp":1758788907000},"page":"101602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["High systemic inflammation response index and increased cardiovascular risk and mortality in MASLD: A prospective cohort study"],"prefix":"10.1016","volume":"7","author":[{"given":"Haixiang","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuangyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9923-9473","authenticated-orcid":false,"given":"Gavino","family":"Casu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Antonio","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8903-5829","authenticated-orcid":false,"given":"Gianpaolo","family":"Vidili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4401-3279","authenticated-orcid":false,"given":"Youren","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2025.101602_bib1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101602_bib2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2025.101602_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101602_bib4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101602_bib5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101602_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/gutjnl-2023-331003","article-title":"Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease","volume":"73","author":"Lee","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2025.101602_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.5009\/gnl210167","article-title":"Innovative target exploration of N consortium. Metabolic dysfunction-associated fatty liver disease predicts long-term mortality and cardiovascular disease","volume":"16","author":"Moon","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.jhepr.2025.101602_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/nu14122361","article-title":"Metabolic dysfunction-associated fatty liver disease is associated with the risk of incident cardiovascular disease: a prospective cohort study in Xinjiang","volume":"14","author":"Guo","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jhepr.2025.101602_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102292","article-title":"Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study","volume":"65","author":"Moon","year":"2023","journal-title":"Eclinicalmedicine"},{"key":"10.1016\/j.jhepr.2025.101602_bib10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12933-024-02434-5","article-title":"Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review","volume":"23","author":"Zheng","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jhepr.2025.101602_bib11","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3390\/ijms23073636","article-title":"Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases","volume":"23","author":"Buonacera","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2025.101602_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/tjem.tjem_198_23","volume":"24","author":"Islam","year":"2024","journal-title":"Turk J Emerg Med"},{"key":"10.1016\/j.jhepr.2025.101602_bib13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.21037\/hbsn-23-631","volume":"13","author":"Gavriilidis","year":"2024","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.jhepr.2025.101602_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13051256","article-title":"Systemic immune-inflammation index and systemic inflammatory response index as predictors of mortality in ST-elevation myocardial infarction","volume":"13","author":"Marchi","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhepr.2025.101602_bib15","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2147\/JIR.S451190","article-title":"The associations of two novel inflammation biomarkers, SIRI and SII, with mortality risk in patients with chronic heart failure","volume":"17","author":"Zhu","year":"2024","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jhepr.2025.101602_bib16","doi-asserted-by":"crossref","first-page":"9553","DOI":"10.3390\/ijms23179553","article-title":"Investigation of the associations of novel inflammatory biomarkers\u2014systemic inflammatory index (SII) and systemic inflammatory response index (SIRI)\u2014with the severity of coronary artery disease and acute coronary syndrome occurrence","volume":"23","author":"Dziedzic","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2025.101602_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1066219","article-title":"Inflammation index SIRI is associated with increased all-cause and cardiovascular mortality among patients with hypertension","volume":"9","author":"Zhao","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jhepr.2025.101602_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1338025","article-title":"Systemic inflammatory response index (SIRI) is associated with all-cause mortality and cardiovascular mortality in population with chronic kidney disease: evidence from NHANES (2001\u20132018)","volume":"15","author":"Gu","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2025.101602_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2024.108055","article-title":"Systemic inflammation response index is associated with increased all-cause and cardiovascular mortality in US adults with rheumatoid arthritis","volume":"185","author":"Wang","year":"2024","journal-title":"Prev Med"},{"key":"10.1016\/j.jhepr.2025.101602_bib20","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.numecd.2023.03.013","article-title":"The association between a novel inflammatory biomarker, systemic inflammatory response index and the risk of diabetic cardiovascular complications","volume":"33","author":"Lin","year":"2023","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jhepr.2025.101602_bib21","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.jacc.2020.04.038","article-title":"Association of age of onset of hypertension with cardiovascular diseases and mortality","volume":"75","author":"Wang","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhepr.2025.101602_bib22","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/CIRCRESAHA.120.317950","article-title":"Arterial stiffness preceding diabetes: a longitudinal study","volume":"127","author":"Zheng","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jhepr.2025.101602_bib23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"European association for the study of diabetes, European association for the study of obesity. EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101602_bib24","article-title":"Association of life\u2019s essential 8 with risk of incident cardiovascular disease and mortality among adults with chronic kidney disease","volume":"22","author":"Huo","year":"2025","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.jhepr.2025.101602_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/JIR.S283835","article-title":"The associations of two novel inflammation indexes, SII and SIRI with the risks for cardiovascular diseases and all-cause mortality: a ten-year follow-up study in 85,154 individuals","volume":"14","author":"Jin","year":"2021","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jhepr.2025.101602_bib26","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.STR.20.10.1407","article-title":"Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO task force on stroke and other cerebrovascular disorders","volume":"20","author":"Stroke","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.jhepr.2025.101602_bib27","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/sim.4264","article-title":"A proportional hazards regression model for the subdistribution with right-censored and left-truncated competing risks data","volume":"30","author":"Zhang","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.jhepr.2025.101602_bib28","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3390\/jcm12031128","article-title":"Systemic immune inflammation index (SII), system inflammation response index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42,875 US adults","volume":"12","author":"Xia","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhepr.2025.101602_bib29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12933-025-02721-9","article-title":"Association between systemic inflammation biomarkers and incident cardiovascular disease in 423,701 individuals: evidence from the UK biobank cohort","volume":"24","author":"Qin","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jhepr.2025.101602_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2024-000718","article-title":"Association between stroke and systemic inflammation response index (SIRI): a national health and nutrition examination survey (NHANES) study 2015\u20132020","volume":"7","author":"Valibeygi","year":"2025","journal-title":"BMJ Neurol Open"},{"key":"10.1016\/j.jhepr.2025.101602_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2024.10.019","article-title":"Association between systemic inflammation markers and cardiovascular mortality in adults with metabolic dysfunction-associated steatotic liver disease","volume":"35","author":"Zhang","year":"2025","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jhepr.2025.101602_bib32","doi-asserted-by":"crossref","first-page":"e748","DOI":"10.1016\/S2214-109X(19)30045-2","article-title":"Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the prospective urban rural epidemiologic (PURE) study","volume":"7","author":"Rosengren","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jhepr.2025.101602_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010841","article-title":"Sex and age differences in the association between metabolic dysfunction-associated fatty liver disease and heart failure: a prospective cohort study","volume":"17","author":"Wu","year":"2024","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jhepr.2025.101602_bib34","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2025.101602_bib35","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","article-title":"Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2","volume":"44","author":"Haukeland","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101602_bib36","article-title":"Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101602_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/jcm14010122","article-title":"Relationship between inflammatory readings and the degree of coronary atherosclerosis (pilot study)","volume":"14","author":"Liuiz\u0117","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhepr.2025.101602_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-025-01307-5","article-title":"Immunopathogenic mechanisms and immunoregulatory therapies in MASLD","author":"He","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhepr.2025.101602_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1437821","article-title":"Immunological perspectives on atherosclerotic plaque formation and progression","volume":"15","author":"Pi","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2025.101602_bib40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2017-06-742676","article-title":"Platelets and vascular integrity: how platelets prevent bleeding in inflammation","volume":"131","author":"Ho-Tin-No\u00e9","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jhepr.2025.101602_bib41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/biom15020163","article-title":"Metabolic dysfunction-associated steatotic liver disease: pathogenetic links to cardiovascular risk","volume":"15","author":"Ionescu","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.jhepr.2025.101602_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1436999","article-title":"Gender differences in the relationship between the systemic immune-inflammation index and all-cause and cardiovascular mortality among adults with hypertension: evidence from NHANES 1999-2018","volume":"15","author":"Cheng","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jhepr.2025.101602_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.683416","article-title":"The cardiovascular and cerebrovascular health in north China from 2006 to 2011: results from the KaiLuan study","volume":"8","author":"Yu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jhepr.2025.101602_bib44","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4330\/wjc.v16.i12.731","article-title":"Trends in cardiovascular and cerebrovascular health scores in the kailuan population from 2006 to 2011","volume":"16","author":"Yu","year":"2024","journal-title":"World J Cardiol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925002848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925002848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T20:34:02Z","timestamp":1772483642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925002848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2589555925002848"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101602","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High systemic inflammation response index and increased cardiovascular risk and mortality in MASLD: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101602"}}